Advantages of StrepSure® - the point-of-care test we are developing 🧪Low cost - US$5-$25 🧪Fast - results in 15 minutes 🧪Accurate - current gold standard sensitivity levels 🧪Easy to use – lateral flow test 🧪Easy to store – good shelf life (1yr+) Group B Strep Support rosie🎃

Testing for #GroupBStrep and knowing your GBS status can help you and your healthcare providers take adequate steps to help protect your baby.

READ article below highlighting the very real affect of food-borne Group B Strep on humans 🌡 #NEXSEN BioTech's point-of-care, lateral flow GBS testing solutions could help alleviate the risk of animal to human transmission 🧪 thefishsite.com/articles/tilap…

"#Nexsen lays out clinical plans for rapid Strep B test development" Medical Technology & Medical Device Network Phalguni Deswal 🔬clinical trial, to be performed and paid for by Northern Health Victoria, expected to start in Q1 2025 medicaldevice-network.com/news/nexsen-la…

The #BirthTraumaInquiry report by the cross party All Party Parliamentary Group is published today and calls on the Government to listen to mums & end the postcode lottery in maternity services. Our headline recommendations to Prime Minister Rishi Sunak: theo-clarke.org.uk/birth-trauma

As a UK report calls for an overhaul of maternity care it is a good time remember that #GBS is is the single largest maternal health problem faced by mums and newborns Nexsen is devloping a rapid, low-cost, easy-to-use, highly accurate point of-care test bbc.co.uk/news/articles/…

It's finally here! Our 2024 Group B Strep in Pregnancy and Babies Virtual Conference! Huge thanks to our chairs, speakers, delegates and sponsors. It's going to be a brilliant day, full of learning. gbss.org.uk/professional-r… GBSSConference2024

If you have already had a baby with #groupBstrep (GBS) disease, you should receive IV antibiotics for GBS during labor and delivery even if you later test negative for GBS in your urine or in a vaginal/rectal swab test for GBS in a current or future pregnancy.

📰 Tom Hanly with Medtech Insight, Citeline Commercial discusses GBS's life-threatening impact on newborn babies, the need for fast, accurate testing and the global opportunity for StrepSure™️ 🧪"If StrepSure™️ is successful, we will save the lives of millions of babies." tinyurl.com/mtzm36nt

We are beyond excited to share the launch of the GBS Aware Portal! Dive into vital resources and join a community dedicated to advancing maternal and infant health at gbsaware.com🌟 #GBSAware #HealthcareInnovation #MaternalHealth #Nexsenbio

📰READ The Independent article on Group B Strep: "mother says baby's common life-threatening condition needs routine NHS testing" #GBS ⚗ NEXSEN are developing an affordable, accurate, rapid, point-of-care testing solution for Group B Strep independent.co.uk/news/health/st…

📰"Group B Streptococcus Detection and Analysis Market is expected to grow at a significant growth rate" 📈 ⚗ At Nexsen we are developing a rapid, point-of-care, lateral flow testing solution to combat the devastating outcomes of GBS prsync.com/imr-market-rep…